https://doi.org/10.1186/s13046-021-01895-w
H
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
485
Citations
13
h-index
14
i10-index
Haibo Zhang is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & PI3K/AKT/mTOR signaling in cancer & Sesquiterpenes and Asteraceae Studies. The author has an h-index of 13, co-authored 25 publications.
ORCID: 0000-0003-3082-8012Papers by this author
worksTargeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis in vitro and in vivo
2021 · Journal of Experimental & Clinical Cancer Research · 66 citations
Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole‐body Diffusion‐weighted <scp>MR</scp> Imaging
2023 · Journal of Magnetic Resonance Imaging · 5 citations
https://doi.org/10.1002/jmri.29155
Retraction Note: Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma
2019 · Cell Death and Disease · 3 citations
https://doi.org/10.1038/s41419-019-1482-8
Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma
2025 · Magnetic Resonance Imaging · 0 citations
https://doi.org/10.1016/j.mri.2025.110536
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat